Skip to main content
Clinical Trials/JPRN-UMIN000043565
JPRN-UMIN000043565
Recruiting
未知

A prospective observational study of T cell subsets after administration of immune checkpoint inhibitors in patients with lung cancer - pharmacodynamics analysis based on T cell subsets of immune checkpoint inhibitors in patients with lung cancer

Kobe City Medical Center General Hospital0 sites50 target enrollmentMarch 9, 2021
Conditionsung cancer

Overview

Phase
未知
Intervention
Not specified
Conditions
ung cancer
Sponsor
Kobe City Medical Center General Hospital
Enrollment
50
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 9, 2021
End Date
March 31, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • inappropriate by the investigator and the investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials